Variant report
Variant | nsv516165 |
---|---|
Chromosome Location | chr6:44523591-44524173 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6939369 | chr6:44523591-44523592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557034580 | chr6:44523610-44523611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs911982 | chr6:44523643-44523644 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs200307510 | chr6:44523668-44523669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs397755692 | chr6:44523669-44523670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140334933 | chr6:44523670-44523671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs199515354 | chr6:44523671-44523672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542583253 | chr6:44523672-44523673 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142170113 | chr6:44523689-44523690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571980394 | chr6:44523697-44523698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528246139 | chr6:44523699-44523700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540041350 | chr6:44523700-44523701 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs59323737 | chr6:44523712-44523713 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs117012155 | chr6:44523742-44523743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs56693922 | chr6:44523835-44523836 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs142190987 | chr6:44523889-44523890 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184264402 | chr6:44523928-44523929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554302466 | chr6:44523930-44523931 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs73436114 | chr6:44523976-44523977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548563131 | chr6:44523991-44523992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529976663 | chr6:44523994-44523995 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538660713 | chr6:44524022-44524023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567172356 | chr6:44524041-44524042 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs137977107 | chr6:44524092-44524093 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534341319 | chr6:44524095-44524096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs543502274 | chr6:44524150-44524151 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552811607 | chr6:44524152-44524153 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7739888 | chr6:44524173-44524174 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Osteosarcoma | 21197465 | CNVD |
Gastric cancer | 24379144 | CNVD |
Neuroblastoma | 18923191 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 16790693 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Chordoma | 18071362 | CNVD |
Follicular lymphoma | 16790693 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Neurocytoma | 17123091 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Ovarian cancer | 20844748 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:44513400-44523800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:44520600-44526600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr6:44523000-44531000 | Weak transcription | Ovary | ovary |
4 | chr6:44523200-44526200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr6:44523600-44524600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr6:44523800-44524000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr6:44523800-44524000 | Enhancers | Gastric | stomach |
8 | chr6:44523800-44524000 | Enhancers | Pancreas | Pancrea |
9 | chr6:44523800-44524200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
10 | chr6:44523800-44527200 | Enhancers | Primary hematopoietic stem cells | blood |
11 | chr6:44523800-44527600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr6:44524000-44525000 | Weak transcription | Pancreas | Pancrea |
13 | chr6:44524000-44527400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr6:44524000-44531000 | Weak transcription | Gastric | stomach |